Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Location
One Edwards Way, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 432 % +21.3%
Quick Ratio 76.1 % -1.9%
Debt-to-equity 28.8 % -20.6%
Return On Equity 13.3 % -75.2%
Return On Assets 10.4 % -73.7%
Operating Margin 24.2 % -5.02%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 580M shares -1.61%
Common Stock, Shares, Outstanding 581M shares -1.54%
Entity Public Float 55.5B USD -2.33%
Common Stock, Value, Issued 658M USD +0.6%
Weighted Average Number of Shares Outstanding, Basic 585M shares -2.09%
Weighted Average Number of Shares Outstanding, Diluted 586M shares -2.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.88B USD +10.6%
Research and Development Expense 1.08B USD +8.58%
Operating Income (Loss) 1.43B USD +5.05%
Nonoperating Income (Expense) 147M USD -20.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.57B USD +7.05%
Income Tax Expense (Benefit) 236M USD +84.7%
Net Income (Loss) Attributable to Parent 1.37B USD -67.1%
Earnings Per Share, Basic 2 USD/shares -66.4%
Earnings Per Share, Diluted 2 USD/shares -66.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.69B USD -27%
Accounts Receivable, after Allowance for Credit Loss, Current 693M USD -3.17%
Inventory, Net 1.14B USD +3.32%
Other Assets, Current 323M USD +40%
Assets, Current 6.36B USD -5.48%
Deferred Income Tax Assets, Net 1.1B USD +23.8%
Property, Plant and Equipment, Net 1.74B USD +4.03%
Operating Lease, Right-of-Use Asset 96.5M USD -7.57%
Intangible Assets, Net (Excluding Goodwill) 1.13B USD +18.3%
Goodwill 1.77B USD +10.2%
Other Assets, Noncurrent 785M USD +14.8%
Assets 13.3B USD +2.32%
Accounts Payable, Current 165M USD -4.51%
Employee-related Liabilities, Current 437M USD +40.1%
Liabilities, Current 1.59B USD -18.3%
Operating Lease, Liability, Noncurrent 75.3M USD -11.4%
Other Liabilities, Noncurrent 363M USD +12.4%
Liabilities 3.07B USD -8.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax -250M USD +0.83%
Retained Earnings (Accumulated Deficit) 14.1B USD +10.7%
Stockholders' Equity Attributable to Parent 10.2B USD +6.91%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 10.2B USD +6.18%
Liabilities and Equity 13.3B USD +2.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 280M USD
Net Cash Provided by (Used in) Financing Activities -258M USD -518%
Net Cash Provided by (Used in) Investing Activities 85.3M USD +35.2%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Shares, Issued 658M shares +0.6%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 90M USD +11.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.69B USD -26.8%
Deferred Tax Assets, Valuation Allowance 87.8M USD +41.4%
Deferred Tax Assets, Gross 1.34B USD +45.1%
Operating Lease, Liability 102M USD +16.1%
Payments to Acquire Property, Plant, and Equipment 56M USD -14.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.37B USD -67%
Lessee, Operating Lease, Liability, to be Paid 114M USD +7.94%
Property, Plant and Equipment, Gross 2.48B USD +8.34%
Operating Lease, Liability, Current 26.8M USD +10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23.3M USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.4M USD -1.49%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.9M USD +50.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.1M USD +17.2%
Deferred Tax Assets, Operating Loss Carryforwards 132M USD +74%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 747M USD +13.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.2M USD +2.33%
Operating Lease, Payments 7M USD -4.11%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 36.6M USD -4.94%
Share-based Payment Arrangement, Expense 153M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%